Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Eur Rev Med Pharmacol Sci. 2024 May;28(10):3532-3541. doi: 10.26355/eurrev_202405_36288.
Free tissue transfer has an established place in oncologic head and neck surgery. However, the necessity and specific regimen of perioperative thromboprophylaxis remain controversial. Here, the risk of postoperative hemorrhage contrasts with vascular pedicle thrombosis and graft loss. This work compares three different heparin protocols (A-C) with regard to postoperative complications.
A retrospective analysis of our free flap transplants between 2004 and 2023 was conducted. Inclusion criteria were thromboprophylaxis with (A) 500 IU/h unfractionated heparin (UFH), (B) low-molecular-weight heparin (LMWH) once daily, and (C) LMWH once daily with additional immediate preoperative administration. Primary endpoints were the incidence of postoperative bleeding and hematoma and the appearance of flap thrombosis.
We evaluated 355 cases, 87 in group A, 179 in group B, and in group C 89 patients. Overall, postoperative bleeding occurred in 8.7% of patients, and 83% underwent hemostasis under intubation anesthesia, with no significant difference between groups (p = 0.784). Hematoma formation requiring revision was found in 3.7% of patients (p = 0.660). We identified postoperative hematoma as a significant influencing factor for venous pedicle thrombosis (OR 3.602; p = 0.001). Venous and arterial flap thrombosis in the graft vessel showed no difference between the groups (p = 0.745 and p = 0.128).
The three anticoagulation regimens appear to be equivalent therapy for the prevention of thrombosis without significant differences in postoperative bleeding. The use of LMWH with additional preoperative administration can, therefore, be administered in free flap reconstruction.
游离组织移植在肿瘤头颈外科中占有重要地位。然而,围手术期血栓预防的必要性和具体方案仍存在争议。在此,术后出血的风险与血管蒂血栓形成和移植物丢失形成对比。本研究比较了三种不同肝素方案(A、B、C)的术后并发症。
对我们 2004 年至 2023 年期间游离皮瓣移植的患者进行回顾性分析。纳入标准为采用(A)500IU/h 未分级肝素(UFH)、(B)低分子肝素(LMWH)每日一次、(C)LMWH 每日一次加术前即刻给药进行血栓预防。主要终点为术后出血和血肿的发生率以及皮瓣血栓形成的出现。
我们评估了 355 例患者,A 组 87 例,B 组 179 例,C 组 89 例。总体而言,8.7%的患者发生术后出血,83%的患者在插管麻醉下进行止血,各组间无显著差异(p=0.784)。需要修正的血肿形成发生率为 3.7%(p=0.660)。我们发现术后血肿是静脉蒂血栓形成的一个显著影响因素(OR 3.602;p=0.001)。移植血管的静脉和动脉皮瓣血栓形成在各组之间无差异(p=0.745 和 p=0.128)。
三种抗凝方案在预防血栓形成方面似乎是等效的治疗方法,术后出血无显著差异。因此,在游离皮瓣重建中可以使用 LMWH 加术前即刻给药。